The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

Investor
Relations.

Founded in 2014, Science 37 provides customers with a platform to empower clinical research while optimizing the experience and outcomes for patients and researchers. The success and future of clinical research demands the ability to activate and provide any patient, regardless of premises; a network of traditional providers, telemedicine providers, mobile nurses, and remote coordinators; and a flexible operating system to seamlessly navigate between on-site and off-site research and care.

For additional information, please contact us at investors@science37.com

Differentiated by the breadth of our technology and virtual capabilities.
From executing a virtual clinical trial, to supplementing as a virtual site, to enabling trials through technology.

Investor Relations.